Journal article
Immunohistochemical detection of ZAP70 in chronic lymphocytic leukemia predicts immunoglobulin heavy chain gene mutation status and time to progression
JH Admirand, RJ Knoblock, KR Coombes, C Tam, EJ Schlette, WG Wierda, A Ferrajoli, S O'Brien, MJ Keating, R Luthra, LJ Medeiros, LV Abruzzo
Modern Pathology | NATURE PUBLISHING GROUP | Published : 2010
Abstract
Zeta-associated protein-70 (ZAP70) expression measured by flow cytometry has been proposed as a surrogate marker of the somatic mutation status of the immunoglobulin heavy chain variable region (IGHV) genes in chronic lymphocytic leukemia. However, attempts to implement this approach in clinical flow cytometry laboratories have been problematic; many commercially available antibodies give unreliable results. Assessment of ZAP70 protein expression by immunohistochemistry in chronic lymphocytic leukemia tissue sections is an easy, alternative approach, although lack of quantitation and subjective interpretation of results are potential pitfalls. In this study, we correlated ZAP70 protein expre..
View full abstractGrants
Awarded by National Cancer Institute
Funding Acknowledgements
This work was supported in part by grants from the CLL Global Research Foundation (LVA) and the National Cancer Institute (LVA, 5R01CA123252-3).